Browse > Article
http://dx.doi.org/10.4014/jmb.2108.08027

Low-Molecular-Weight Collagen Peptide Ameliorates Osteoarthritis Progression through Promoting Extracellular Matrix Synthesis by Chondrocytes in a Rabbit Anterior Cruciate Ligament Transection Model  

Lee, Mun-Hoe (Health Food Research and Development, NEWTREE Co., Ltd.)
Kim, Hyeong-Min (Health Food Research and Development, NEWTREE Co., Ltd.)
Chung, Hee-Chul (Health Food Research and Development, NEWTREE Co., Ltd.)
Kim, Do-Un (Health Food Research and Development, NEWTREE Co., Ltd.)
Lee, Jin-Hee (Health Food Research and Development, NEWTREE Co., Ltd.)
Publication Information
Journal of Microbiology and Biotechnology / v.31, no.10, 2021 , pp. 1401-1408 More about this Journal
Abstract
This study examined whether the oral administration of low-molecular-weight collagen peptide (LMCP) containing 3% Gly-Pro-Hyp with >15% tripeptide (Gly-X-Y) content could ameliorate osteoarthritis (OA) progression using a rabbit anterior cruciate ligament transection (ACLT) model of induced OA and chondrocytes isolated from a patient with OA. Oral LMCP administration (100 or 200 mg/kg/day) for 12 weeks ameliorated cartilage damage and reduced the loss of proteoglycan compared to the findings in the ACLT control group, resulting in dose-dependent (p < 0.05) improvements of the OARSI score in hematoxylin & eosin (H&E) and Safranin O staining. In micro-computed tomography analysis, LMCP also significantly (p < 0.05) suppressed the deterioration of the microstructure in tibial subchondral bone during OA progression. The elevation of IL-1β and IL-6 concentrations in synovial fluid following OA induction was dose-dependently (p < 0.05) reduced by LMCP treatment. Furthermore, immunohistochemistry illustrated that LMCP significantly (p < 0.05) upregulated type II collagen and downregulated matrix metalloproteinase-13 in cartilage tissue. Consistent with the in vivo results, LMCP significantly (p < 0.05) increased the mRNA expression of COL2A1 and ACAN in chondrocytes isolated from a patient with OA regardless of the conditions for IL-1β induction. These findings suggest that LMCP has potential as a therapeutic treatment for OA that stimulates cartilage regeneration.
Keywords
Osteoarthritis; ACLT rabbit; chondrocyte; collagen hydrolysate; low-molecular-weight collagen peptide; cartilage regeneration;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Glyn-Jones S, Palmer A, Agricola R, Price A, Vincent T, Weinans H, et al. 2015. Osteoarthritis. Lancet 386: 376-387.   DOI
2 Le Graverand-Gastineau MP. 2010. Disease modifying osteoarthritis drugs: facing development challenges and choosing molecular targets. Curr. Drug Targets 11: 528-535.   DOI
3 Liu Z, Hu X, Man Z, Zhang J, Jiang Y, Ao Y. 2016. A novel rabbit model of early osteoarthritis exhibits gradual cartilage degeneration after medial collateral ligament transection outside the joint capsule. Sci. Rep. 6: 34423.   DOI
4 Naraoka T, Ishibashi Y, Tsuda E, Yamamoto Y, Kusumi T, Toh S. 2013. Periodic knee injections of collagen tripeptide delay cartilage degeneration in rabbit experimental osteoarthritis. Arthritis Res. Ther. 15: R32.   DOI
5 Sandell LJ, Aigner T. 2001. Articular cartilage and changes in arthritis: cell biology of osteoarthritis. Arthritis Res. Ther. 3: 1-7.   DOI
6 Imhof H, Sulzbacher I, Grampp S, Czerny C, Youssefzadeh S, Kainberger F. 2000. Subchondral bone and cartilage disease: a rediscovered functional unit. Invest. Radiol. 35: 581-588.   DOI
7 Lee SA, Moon SM, Han SH, Hwang EJ, Park BR, Kim JS, et al. 2018. Chondroprotective effects of aqueous extract of Anthriscus sylvestris leaves on osteoarthritis in vitro and in vivo through MAPKs and NF-κB signaling inhibition. Biomed. Pharmacother. 103: 1202-1211.   DOI
8 Kwon JY, Lee SH, Na HS, Jung K, Choi J, Cho KH, et al. 2018. Kartogenin inhibits pain behavior, chondrocyte inflammation, and attenuates osteoarthritis progression in mice through induction of IL-10. Sci. Rep. 8: 13832.   DOI
9 Gao Y, Liu S, Huang J, Guo W, Chen J, Zhang L, et al. 2014. The ECM-cell interaction of cartilage extracellular matrix on chondrocytes. Biomed. Res. Int. 2014: 648459.
10 Yang CY, Chanalaris A, Troeberg L. 2017. ADAMTS and ADAM metalloproteinases in osteoarthritis-looking beyond the 'usual suspects'. Osteoarthritis Cartilage 25: 1000-1009.   DOI
11 Grynpas MD, Alpert B, Katz I, Lieberman I, Pritzker KP. 1991. Subchondral bone in osteoarthritis. Calcif. Tissue Int. 49: 20-26.   DOI
12 Klocke R, Levasseur K, Kitas GD, Smith JP, Hirsch G. 2018. Cartilage turnover and intra-articular corticosteroid injections in knee osteoarthritis. Rheumatol. Int. 38: 455-459.   DOI
13 Ricci M, Micheloni GM, Berti M, Perusi F, Sambugaro E, Vecchini E, et al. 2017. Clinical comparison of oral administration and viscosupplementation of hyaluronic acid (HA) in early knee osteoarthritis. Musculoskelet. Surg. 101: 45-49.   DOI
14 Shigemura Y, Iwai K, Morimatsu F, Iwamoto T, Mori T, Oda C, et al. 2009. Effect of prolyl-hydroxyproline (Pro-Hyp), a food-derived collagen peptide in human blood, on growth of fibroblasts from mouse skin. J. Agric. Food Chem. 57: 444-449.   DOI
15 Pyun HB, Kim M, Park J, Sakai Y, Numata N, Shin JY, et al. 2012. Effects of collagen tripeptide supplement on photoaging and epidermal skin barrier in UVB-exposed hairless mice. Prev. Nutr. Food Sci. 17: 245-253.   DOI
16 Laverty S, Girard CA, Williams JM, Hunziker EB, Pritzker KP. 2010. The OARSI histopathology initiative-recommendations for histological assessments of osteoarthritis in the rabbit. Osteoarthritis Cartilage 18 Suppl 3: S24-S34.
17 Hu ZC, Luo ZC, Jiang BJ, Fu X, Xuan JW, Li XB, et al. 2019. The protective effect of magnolol in osteoarthritis: in vitro and in vivo studies. Front. Pharmacol. 10: 393.   DOI
18 Konig D, Oesser S, Scharla S, Zdzieblik D, Gollhofer A. 2018. Specific collagen peptides improve bone mineral density and bone markers in postmenopausal women-a randomized controlled study. Nutrients 10: 97.   DOI
19 Postlethwaite AE, Seyer JM, Kang AH. 1978. Chemotactic attraction of human fibroblasts to type I, II, and III collagens and collagen-derived peptides. Proc. Natl. Acad. Sci. USA 75: 871-875.   DOI
20 Gamble R, Wyeth-Ayerst J, Johnson EL. 2000. Recommendations for the medical management of osteoarthritis of the hip and knee. Arthritis Rheum. 43: 1905-1915.   DOI
21 Song H, Li B. 2017. Beneficial effects of collagen hydrolysate: a review on recent developments. Biomed. J. Sci. Tech. Res. 1: 1-4.
22 Min G. 2017. Collagen hydrolysate Gly-Pro-Hyp on osteoblastic proliferation and differentiation of MC3T3-E1 cells. J. Clin. Nurs. Res. 1: 40-46.
23 Yazaki M, Ito Y, Yamada M, Goulas S, Teramoto S, Nakaya MA, et al. 2017. Oral ingestion of collagen hydrolysate leads to the transportation of highly concentrated Gly-Pro-Hyp and its hydrolyzed form of Pro-Hyp into the bloodstream and skin. J. Agric. Food Chem. 65: 2315-2322.   DOI
24 Okawa T, Yamaguchi Y, Takada S, Sakai Y, Numata N, Nakamura F, et al. 2012. Oral administration of collagen tripeptide improves dryness and pruritus in the acetone-induced dry skin model. J. Dermatol. Sci. 66: 136-143.   DOI
25 Dong C, Lv Y. 2016. Application of collagen scaffold in tissue engineering: recent advances and new perspectives. Polymers 8: 42.   DOI
26 Pereira H, Cengiz IF, Vilela C, Ripoll PL, Espregueira-Mendes J, Oliveira JM, et al. 2018. Emerging concepts in treating cartilage, osteochondral defects, and osteoarthritis of the knee and ankle. Adv. Exp. Med. Biol. 1059: 25-62.   DOI
27 Pritzker KP, Gahunia HK. 2020. Histopathology evaluation of cartilage disease and repair, pp. 371-388. Articular Cartilage of the Knee, Ed. Springer.
28 Kiani C, Chen L, Wu YJ, Yee AJ, Yang BB. 2002. Structure and function of aggrecan. Cell Res. 12: 19-32.   DOI
29 Jeong DH, Ullah HMA, Goo MJ, Ghim SG, Hong IH, Kim AY, et al. 2018. Effects of oral glucosamine hydrochloride and mucopolysaccharide protein in a rabbit model of osteoarthritis. Int. J. Rheum. Dis. 21: 620-628.   DOI
30 Jiang J, Cai M. 2021. Cardamonin inhibited IL-1β-induced injury by inhibition of NLRP3 inflammasome via activating Nrf2/NQO1 signaling pathway in chondrocyte. J. Microbiol. Biotechnol. 31: 794-802.   DOI
31 Tsuruoka N, Yamato R, Sakai Y, Yoshitake Y, Yonekura H. 2007. Promotion by collagen tripeptide of type I collagen gene expression in human osteoblastic cells and fracture healing of rat femur. Biosci. Biotechnol. Biochem. 71: 2680-2687.   DOI
32 Pritzker KP, Gay S, Jimenez SA, Ostergaard K, Pelletier JP, Revell PA, et al. 2006. Osteoarthritis cartilage histopathology: grading and staging. Osteoarthr. Cartil. 14: 13-29.   DOI
33 Yamamoto S, Hayasaka F, Deguchi K, Okudera T, Furusawa T, Sakai Y. 2015. Absorption and plasma kinetics of collagen tripeptide after peroral or intraperitoneal administration in rats. Biosci. Biotechnol. Biochem. 79: 2026-2033.   DOI
34 Kim DU, Chung HC, Choi J, Sakai Y, Lee BY. 2018. Oral intake of low-molecular-weight collagen peptide improves hydration, elasticity, and wrinkling in human skin: a randomized, double-blind, placebo-controlled study. Nutrients 10: 826.   DOI
35 Kim J-K, Lee J-H, Yang M-S, Seo D-B, Lee S-J. 2009. Beneficial effect of collagen peptide supplement on anti-aging against photodamage. Korean J. Food Sci. Technol. 41: 441-445.